Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma
Vladimir Bilim(Yamagata University), Yoshihiko Tomita(Niigata University)
Cited by 107
Related Papers
9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer
|Scientific Reports|2019|60
Double inhibition of XIAP and Bcl-2 axis is beneficial for retrieving sensitivity of renal cell cancer to apoptosis
|British Journal of Cancer|2008|49
Targeting Pro-Survival Autophagy Enhanced GSK-3β Inhibition-Induced Apoptosis and Retarded Proliferation in Bladder Cancer Cells
|Current Oncology|2023|3
MicroRNAs as Potential Regulators of GSK-3β in Renal Cell Carcinoma
|Current Issues in Molecular Biology|2023|2